Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 1031

1.

Reversal of multidrug resistance of cancer through inhibition of P-glycoprotein by 5-bromotetrandrine.

Jin J, Wang FP, Wei H, Liu G.

Cancer Chemother Pharmacol. 2005 Feb;55(2):179-88. Epub 2004 Sep 16.

PMID:
15378274
2.

MDR reversal activity of bromotetrandrine in vitro and in vivo.

Cheng J, Wang JQ, Chen BA, Gao F, Xu WL, Shen HL, Ding JH, Gao C, Sun YY, Wang J, Zhao G, Song HH, Bao W, Sun Q, Dai YY, Sun XC, Cheng HY, Deng YX, Li GH, Chen NN, Liu LJ, Wang XM.

Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2009 Oct;17(5):1183-91.

PMID:
19840447
3.

Reversal of P-glycoprotein-mediated multidrug resistance of cancer cells by five schizandrins isolated from the Chinese herb Fructus Schizandrae.

Huang M, Jin J, Sun H, Liu GT.

Cancer Chemother Pharmacol. 2008 Nov;62(6):1015-26. doi: 10.1007/s00280-008-0691-0. Epub 2008 Feb 13.

PMID:
18270702
4.
5.

Reversal of P-gp mediated multidrug resistance in-vitro and in-vivo by FG020318.

Chen LM, Liang YJ, Ruan JW, Ding Y, Wang XW, Shi Z, Gu LQ, Yang XP, Fu LW.

J Pharm Pharmacol. 2004 Aug;56(8):1061-6.

PMID:
15285852
6.

Reversal of P-gp-mediated multidrug resistance by Bromotetrandrine in vivo is associated with enhanced accumulation of chemotherapeutical drug in tumor tissue.

Chen LM, Liang YJ, Zhang X, Su XD, Dai CL, Wang FP, Yan YY, Tao LY, Fu LW.

Anticancer Res. 2009 Nov;29(11):4597-604.

7.
8.
10.

Characterization of tetrandrine, a potent inhibitor of P-glycoprotein-mediated multidrug resistance.

Fu L, Liang Y, Deng L, Ding Y, Chen L, Ye Y, Yang X, Pan Q.

Cancer Chemother Pharmacol. 2004 Apr;53(4):349-56. Epub 2003 Dec 10.

PMID:
14666379
12.

Reversal of cancer multidrug resistance by green tea polyphenols.

Mei Y, Qian F, Wei D, Liu J.

J Pharm Pharmacol. 2004 Oct;56(10):1307-14.

PMID:
15482646
13.

In vitro and in vivo reversal of P-glycoprotein-mediated multidrug resistance by a novel potent modulator, XR9576.

Mistry P, Stewart AJ, Dangerfield W, Okiji S, Liddle C, Bootle D, Plumb JA, Templeton D, Charlton P.

Cancer Res. 2001 Jan 15;61(2):749-58.

14.

Reversal of MDR1/P-glycoprotein-mediated multidrug resistance by vector-based RNA interference in vitro and in vivo.

Shi Z, Liang YJ, Chen ZS, Wang XW, Wang XH, Ding Y, Chen LM, Yang XP, Fu LW.

Cancer Biol Ther. 2006 Jan;5(1):39-47. Epub 2006 Jan 12.

PMID:
16319528
15.

[Reversal of multidrug resistance of tumor cells by FG020327 and its mechanism].

Chen LM, Li YF, Zhang X, Yan SL, Liang YJ, Fu LW.

Ai Zheng. 2005 Feb;24(2):189-93. Chinese.

PMID:
15694031
16.
17.
18.
19.

Reversal of doxorubicin resistance in multidrug resistant melanoma cells in vitro and in vivo by dipyridamole.

Desai PB, Duan J, Sridhar R, Damle BD.

Methods Find Exp Clin Pharmacol. 1997 May;19(4):231-9.

PMID:
9228648
20.

Development of rational in vitro models for drug resistance in breast cancer and modulation of MDR by selected compounds.

Kars MD, Iseri OD, Gündüz U, Ural AU, Arpaci F, Molnár J.

Anticancer Res. 2006 Nov-Dec;26(6B):4559-68.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk